Skrining serologis antibodi IgG dan IgM leptospira pada masyarakat yang tinggal di wilayah berisiko di Kota Manado

DOI: https://doi.org/10.33024/hjk.v20i6.3795

Authors

  • Kevin Giovani Pascoal Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado
  • Linda Agustien Makalew Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado
  • Jonas Edrian Sumampouw Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado
  • Sabrina Prisscilya Magdalena Pinontoan Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado
  • Muhammad Ali Makaminan Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado
  • Elne Vieke Rambi Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado
  • Michael Vallery Loueis Tumbol Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado
  • Muh Taufiq Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado
  • Muh Taufiq Jurusan Teknologi laboratorium Medis, Poltekkes Kemenkes Manado

IgG IgM Leptospira Leptospirosis Serological Screening

Abstract

Background: Leptospirosis is a zoonotic disease that remains a significant public health concern in tropical regions. Manado City possesses several environmental conditions that may facilitate Leptospira transmission, including frequent flooding and the presence of rodents. However, information regarding the serological status of communities living in high-risk areas remains limited, and potential exposure not identified through routine case-based surveillance is still unclear.

Purpose: To determine the serological reactivity of anti-Leptospira IgG and IgM antibodies among individuals living in high-risk areas of Manado City.

Method: A descriptive study was conducted from January to May 2025 in Manado City, Indonesia. A total of 221 participants were recruited using purposive sampling based on residence in leptospirosis-prone areas. Anti-Leptospira IgG and IgM antibodies were detected using a rapid diagnostic test (RDT), while participants' demographic and environmental characteristics were collected through a structured questionnaire. Data were analyzed descriptively and presented as frequencies, percentages, and narrative descriptions.

Results: The mean age of the participants was 43.68 ± 12.37 years, with most respondents aged 18–59 years (88.7%), male (75.1%), and employed as laborers (43.9%). Most participants reported living in flood-affected households (74.7%) and in environments where rodents were present (96.4%). Serological testing revealed that 219 participants (99.1%) were negative for both IgG and IgM antibodies, while two participants (0.9%) were positive for IgM and negative for IgG. No participants were positive for IgG antibodies.

Conclusion: Although most participants lived in environments characterized by recognized risk factors for leptospirosis, including flooding and rodent exposure, serological reactivity to Leptospira was low. These findings provide baseline information on the serological status of communities residing in high-risk areas and support the importance of continuous surveillance through serological screening complemented by confirmatory methods such as the Microscopic Agglutination Test (MAT) or Polymerase Chain Reaction (PCR) to obtain a more comprehensive understanding of leptospirosis epidemiology.

Suggestion: Future research should employ confirmatory methods such as the Microscopic Agglutination Test (MAT) and/or molecular testing based on Polymerase Chain Reaction (PCR) to confirm serological screening results and improve the accuracy of Leptospira infection identification.

 

Keywords: IgG; IgM; Leptospira; Leptospirosis; Serological Screening.

Downloads

Download data is not yet available.

References

Baharom, M., Ahmad, N., Hod, R., Ja’afar, M. H., Arsad, F. S., Tangang, F., & Osman, Y. (2024). Environmental and occupational factors associated with leptospirosis: A systematic review. Heliyon, 10(1).

Bradley, E. A., & Lockaby, G. (2023). Leptospirosis and the environment: a review and future directions. Pathogens, 12(9), 1167.

Ciurariu, E., Prodan-Barbulescu, C., Mateescu, D. M., Tutac, P., Sorop, V. B., Susan, M., & Varga, N. I. (2025). Diagnostic advances in leptospirosis: a comparative analysis of paraclinical tests with a focus on PCR. Microorganisms, 13(3), 667.

Clemente, B. M., Pineda-Cortel, M. R., & Villaflores, O. (2022). Evaluating immunochromatographic test kits for diagnosis of acute human leptospirosis: A systematic review. Heliyon, 8(11).

Costa, F., Hagan, J. E., Calcagno, J., Kane, M., Torgerson, P., Martinez-Silveira, M. S., & Ko, A. I. (2015). Global morbidity and mortality of leptospirosis: a systematic review. PLoS neglected tropical diseases, 9(9), e0003898.

Dehkordi, A. G., Al-Tamary, S. R. S., Al-Tamary, A. R. S., Al-Tamary, H. R. S., Albarari, S. S. A., Assad, A. M. Z., & Mikadze, I. (2024). Atypical cases of leptospirosis: insights from Georgia. Case Reports in Infectious Diseases, 2024(1), 1414417.

Haq, A., Anggraini, S., & Masnarivan, Y. (2019). Environmental factors related to leptospirosis in Indonesia: a systematic review. In AIPHC 2019: Proceedings of the Third Andalas International Public Health Conference, AIPHC 2019, 10-11th October 2019, Padang, West Sumatera, Indonesia (p. 308). European Alliance for Innovation.

Ilma, K., Martini, M., & Raharjo, M. R. M. (2022). Spatial Analysis and Risk Factors of Leptospirosis in Indonesia. A Systematic Review. Journal of Community Medicine and Public Health Research [Internet], 129-39.

Muñoz-Zanzi, C., Dreyfus, A., Limothai, U., Foley, W., Srisawat, N., Picardeau, M., & Haake, D. A. (2025). Leptospirosis—improving healthcare outcomes for a neglected tropical disease. In Open Forum Infectious Diseases (Vol. 12, No. 2, p. ofaf035). US: Oxford University Press.

Naing, C., Reid, S. A., Aye, S. N., Htet, N. H., & Ambu, S. (2019). Risk factors for human leptospirosis following flooding: A meta-analysis of observational studies. PloS one, 14(5), e0217643.

Nova, R. I. T., & Herdhianta, D. (2025). Environmental Risk Factors Associated with Leptospirosis Cases in Human: a Systematic Review. Buletin Keslingmas, 44(4), 299-314.

Nualnoi, T., Lomlim, L., & Naorungroj, S. (2024). Accuracy of rapid lateral flow immunoassays for human leptospirosis diagnosis: a systematic review and meta-analysis. PLoS Neglected Tropical Diseases, 18(5), e0012174.

Rajapakse, S. (2022). Leptospirosis: clinical aspects. Clinical Medicine, 22(1), 14-17.

Samrot, A. V., Sean, T. C., Bhavya, K. S., Sahithya, C. S., Chan-Drasekaran, S., Palanisamy, R., & Mok, P. L. (2021). Leptospiral infection, pathogenesis and its diagnosis—a review. Pathogens, 10(2), 145.

Sayanthi, Y., & Susanna, D. (2024). Pathogenic Leptospira contamination in the environment: a systematic review. Infection Ecology & Epidemiology, 14(1), 2324820.

Setiawan, A., Setiyadi, N. A., & Murti, B. (2024). Analysis of Environmental Risk Factors for Leptospirosis in Bantul, Yogyakarta, Indonesia. Journal of Epidemiology and Public Health, 9(4), 425-436.

Sykes, J. E., Reagan, K. L., Nally, J. E., Galloway, R. L., & Haake, D. A. (2022). Role of diagnostics in epidemiology, management, surveillance, and control of leptospirosis. Pathogens, 11(4), 395.

Valente, M., Bramugy, J., Keddie, S. H., Hopkins, H., Bassat, Q., Baerenbold, O., & Crump, J. A. (2024). Diagnosis of human leptospirosis: systematic review and meta-analysis of the diagnostic accuracy of the Leptospira microscopic agglutination test, PCR targeting Lfb1, and IgM ELISA to Leptospira fainei serovar Hurstbridge. BMC infectious diseases, 24(1), 168.

Wang, S., & Dunn, N. (2024). Leptospirosis. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441858/

Yuniasih, D., Ihsana, N., Shalsabila, D. A., & Sukirto, N. W. (2022). Systematic Review: Epidemiology of Leptospirosis in Indonesia. J Kesehat Masy, 10(5), 544-9.

Downloads

Published

2026-08-31